Maynard Um
-
-
-
-
-
-
-
Polyrizon partners with Clearmind to develop intranasal MEAI formulation
-
-
-
-
-
-
-
Clearmind Medicine (CMND) files for 5.78M share offering by selling stockholders
-
-
-
-
-
-
-
Clearmind Medicine completes first cohort in alcohol disorder trial
-
-
-
-
-
-
-
Clearmind Medicine (CMND) files for 17.02M share offering by selling stockholders
-
-
-
-
-
-
-
Clearmind Medicine (CMND) Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder
-
-
-
-
-
-
-
Clearmind Medicine (CMND) Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism
-
-
-
-
-
-
-
Clearmind Medicine (CMND) Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

